1. Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice. (March 2019) Authors: Giorgio, C.; Incerti, M.; Pala, D.; Russo, S.; Chiodelli, P.; Rusnati, M.; Cantoni, A.M.; Di Lecce, R.; Barocelli, E.; Bertoni, S.; Ravassard, P.; Manenti, F.; Piemonti, L.; Ferlenghi, F.; Lodola, A.; Tognolini, M. Journal: Pharmacological research Issue: Volume 141(2019) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeting glioblastoma with UniPR1331, a new and stable bioavailable small molecule inhibiting Eph–ephrin interaction: In vitro and in vivo evidence. (December 2016) Authors: Festuccia, C.; Giorgio, C.; Gravina, G.L.; Castelli, R.; Vacondio, F.; Rusnati, M.; Chiodelli, P.; Barocelli, E.; Lodola, A.; Tognolini, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗